Abstract
Glioma is the most common and fatal primary brain tumor. Thus far, therapeutic strategies to efficiently and specifically antagonize glioma are limited and poorly developed. Here we report that glia-enriched miR-135a, a microRNA that is dramatically downregulated in malignant glioma and correlated with the pathological grading, is capable of inducing mitochondria-dependent apoptosis of malignant glioma by regulating various genes including STAT6, SMAD5 and BMPR2, as well as affecting the signaling pathway downstream. Moreover, this lethal effect is selectively towards malignant glioma cells, but not neurons and glial cells, through a novel mechanism. Our findings suggest an important role of miR-135a in glioma etiology and provide a potential candidate for malignant glioma therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altieri DC . (2008). Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61–70.
Beduneau A, Saulnier P, Benoit JP . (2007). Active targeting of brain tumors using nanocarriers. Biomaterials 28: 4947–4967.
Bomben VC, Sontheimer H . (2010). Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas. Glia 58: 1145–1156.
Budihardjo I, Oliver H, Lutter M, Luo X, Wang XD . (1999). Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Bi 15: 269–290.
Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C et al. (2007). Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456–2468.
Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A . (2008). miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 48: 648–656.
Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G et al. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125–9130.
Hammell CM, Lubin I, Boag PR, Blackwell TK, Ambros V . (2009). nhl-2 modulates microRNA activity in Caenorhabditis elegans. Cell 136: 926–938.
Hsu SD, Chu CH, Tsou AP, Chen SJ, Chen HC, Hsu PW et al. (2008). miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes. Nucleic Acids Res 36: D165–D169.
Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X et al. (2009). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37: D98–D104.
Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP et al. (2009). Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell 36: 487–499.
Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005–1017.
Kumar B, Hovland AR, Prasad JE, Clarkson E, Cole WC, Nahreini P et al. (2001). Establishment of human embryonic brain cell lines. In Vitro Cell Dev Biol Anim 37: 259–262.
Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . (2002). Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735–739.
Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.
Li KK, Pang JC, Ching AK, Wong CK, Kong X, Wang Y et al. (2009). miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40: 1234–1243.
Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM et al. (2008). A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 105: 13906–13911.
Lim M, Zhong C, Yang S, Bell AM, Cohen MB, Roy-Burman P . (2010). Runx2 regulates survivin expression in prostate cancer cells. Lab Invest 90: 222–233.
Liu Z, Shen J, Pu K, Katus HA, Ploger F, Tiefenbacher CP et al. (2009). GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP. Biochim Biophys Acta 1793: 1819–1827.
Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE et al. (2010). Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20: 539–550.
Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, Dalamagas T et al. (2009). DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 37(Suppl. S): W273–W276.
Masuda A, Matsuguchi T, Yamaki K, Hayakawa T, Yoshikai Y . (2001). Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J Biol Chem 276: 26107–26113.
Nagel R, le Sage C, Diosdado B, van der Waal M, Oude VJ, Bolijn A et al. (2008). Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68: 5795–5802.
Nahreini P, Andreatta C, Kumar B, Hanson A, Edwards-Prasad J, Freed CR et al. (2003). Distinct patterns of gene expression induced by viral oncogenes in human embryonic brain cells. Cell Mol Neurobiol 23: 27–42.
Navarro A, Diaz T, Martinez A, Gaya A, Pons A, Gel B et al. (2009). Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood 114: 2945–2951.
Nilsen TW . (2007). Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 23: 243–249.
Rebholz-Schuhmann D, Kirsch H, Arregui M, Gaudan S, Riethoven M, Stoehr P . (2007). EBIMed—text crunching to gather facts for proteins from medline. Bioinformatics 23: e237–e244.
Ritchie W, Flamant S, Rasko JE . (2010). mimiRNA: a microRNA expression profiler and classification resource designed to identify functional correlations between microRNAs and their targets. Bioinformatics 26: 223–227.
Schwamborn JC, Berezikov E, Knoblich JA . (2009). The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 136: 913–925.
Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M et al. (2008). miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14.
Siomi H, Siomi MC . (2010). Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38: 323–332.
Sun Y, Zhou J, Liao X, Lu Y, Deng C, Huang P et al. (2005). Disruption of Smad5 gene induces mitochondria-dependent apoptosis in cardiomyocytes. Exp Cell Res 306: 85–93.
Wen PY, Kesari S . (2008). Malignant gliomas in adults. N Engl J Med 359: 492–507.
Wurster AL, Rodgers VL, White MF, Rothstein TL, Grusby MJ . (2002). Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem 277: 27169–27175.
Yang S, Lim M, Pham LK, Kendall SE, Reddi AH, Altieri DC et al. (2006). Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. Cancer Res 66: 4285–4290.
Yang YL, Li XM . (2000). The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 10: 169–177.
Zhang WJ, Li BH, Yang XZ, Li PD, Yuan Q, Liu XH et al. (2008). IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells. Cytokine 42: 39–47.
Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X et al. (2009). MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med 87: 43–51.
Acknowledgements
This work was supported by Key program, National Natural Science Foundation of China (No. 30830111), Guangzhou Scientific and Technological program (No. 2008Z1-E561) and Guangdong Natural Science Foundation (No. S2011040004371).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Wu, S., Lin, Y., Xu, D. et al. MiR-135a functions as a selective killer of malignant glioma. Oncogene 31, 3866–3874 (2012). https://doi.org/10.1038/onc.2011.551
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.551
Keywords
This article is cited by
-
Loss of monocarboxylate transporter 1 aggravates white matter injury after experimental subarachnoid hemorrhage in rats
Frontiers of Medicine (2021)
-
Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK)
Digestive Diseases and Sciences (2020)
-
Functional role of microRNA-135a in colitis
Journal of Inflammation (2018)
-
Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes
Genes & Genomics (2018)
-
MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma
Journal of Neuro-Oncology (2018)